Levi & Korsinsky is investigating the Board of Directors of Liberator Medical Holdings, Inc. (NYSE MKT: LBMH) in connection with the sale of the Company to C. R. Bard, Inc. (NYSE: BCR). Under the terms of the transaction, Liberator Medical shareholders will receive $3.35 in cash for each share of Liberator Medical stock they own.
The investigation concerns whether the Board of Liberator Medical breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether C. R. Bard, Inc. is underpaying for Liberator Medical shares. In particular, at least one analyst set a price target of $8.00 per Liberator Medical share.
To receive more information, please fill out the form.